In addition to providing new mechanistic insights into the synergistic interaction of Bortezomib and TRAIL the present study is the first demonstration that Bortezomib acts in concert with TRAIL in a childhood cancer, i.e. neuroblastoma. Here, TNFSF10 is linked to childhood malignant neoplasm.